Bradesco stock price nears $4: what to watch after the payout tweak and Brazil rate bets
25 January 2026
2 mins read

Bradesco stock price nears $4: what to watch after the payout tweak and Brazil rate bets

SAO PAULO, Jan 25, 2026, 08:15 BRT — The market has closed.

Banco Bradesco S.A.’s American depositary shares (NYSE: BBD) climbed 2.5% to close at $3.95 on Friday, hitting a session peak of $3.97 earlier in the day.

The late-week rally followed a new shareholder-payments update from the Brazilian lender. This came amid ongoing chatter about yield and the bigger issue: the timing of Brazil’s rate cycle shift.

Timing is crucial here. Bradesco distributes monthly payments to shareholders through “interest on shareholders’ equity,” which works like a dividend. Even slight shifts in these net payouts can sway valuation models, especially as the market is actively recalculating cash returns.

In a Form 6-K dated Jan. 23, Bradesco announced an adjustment to the income tax rate and net per-share values for its 2026 monthly “interest on shareholders’ equity” payments, following the release of Supplementary Law No. 224/25. The bank kept the gross monthly payments steady at R$0.017249826 per common share and R$0.018974809 per preferred share. Net amounts were set at R$0.014231106 and R$0.015654217, reflecting a 17.5% withholding tax. Signed by investor relations officer André Costa Carvalho, the notice confirmed the payment schedule would “remain unchanged,” with the January reference-month payment slated for Feb. 2.

Interest on shareholders’ equity — known as JCP in Brazil — functions as a cash payout to investors but is taxed differently than a regular dividend under local rules. That means changes to tax rates quickly affect what shareholders end up with.

Rates remain the key focus. A Reuters poll on Friday revealed economists are betting Brazil’s central bank will keep the Selic rate steady at 15% on Jan. 28, with most expecting the first cut to arrive in March. Stephan Kautz, chief economist at EQI Asset, noted the upcoming statement might drop language about resuming hikes. Meanwhile, BNP Paribas economist Laiz Carvalho pointed to household spending as the growth driver, fueled by consumption stimulus measures set for late 2025 and early 2026. 1

This environment is crucial for Bradesco and other major Brazilian banks, as rate cuts can boost credit demand and make debt payments more manageable, though they also squeeze the lending spreads these banks rely on. Itaú Unibanco, Banco do Brasil, and Santander Brasil usually follow similar policy cues.

Bradesco’s next key event is just around the corner. The bank remains in a quiet period until Feb. 5, when it will report its fourth-quarter results after the close in São Paulo and New York, per its investor relations calendar. A videoconference to discuss the earnings is scheduled for Feb. 6 at 08:30 a.m. U.S. Eastern time, with simultaneous English translation provided. 2

As the numbers come in, traders will zero in on loan growth, bad loan provisions, and whether profits are still nudging up. A shift in the tone on capital returns could steal the spotlight from the mechanical payout adjustment revealed last week.

There’s a clear risk, though: inflation expectations might stop falling, keeping policymakers cautious and rates pinned at 15% longer than markets anticipate. That scenario would maintain steep borrowing costs, putting pressure on weaker borrowers—a combination that has weighed on Brazilian bank sentiment in the past.

The next key event is the central bank decision on Jan. 28, followed by Bradesco’s earnings report on Feb. 5. Policymakers’ language and the bank’s outlook on credit and margins will drive what happens next.

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
IREN stock pops 8% as Feb. 5 results near — bitcoin difficulty and AI cloud bets back in play
Previous Story

IREN stock pops 8% as Feb. 5 results near — bitcoin difficulty and AI cloud bets back in play

Redwire stock price jumps on Golden Dome buzz — what to watch when markets reopen
Next Story

Redwire stock price jumps on Golden Dome buzz — what to watch when markets reopen

Go toTop